Islet Sciences Inc (ISLT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Islet Sciences Inc (Islet Sciences) pharmaceutical company that develops medicines and technologies for the treatment of metabolic diseases. The company pipeline includes immune modulating small molecule interleukin 12 inhibitors to address disorders associated with inflammation. It offers cell therapy based artificial pancreas for the treatment of type 1 diabetes. The company offers diagnostics, therapeutics and infusion products. Its diagnostic products are used in determining the progression of disease and guide its treatment in diabetic patients and the prognosis of islet or pancreas graft recipients. Islet Sciences is headquartered in Yorba Linda, California, the US.

Islet Sciences Inc (ISLT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Islet Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Islet Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Islet Sciences Raises USD0.03 Million in Financing Round 11
Islet Sciences Raises US$0.7 Million In Venture Financing 12
Islet Sciences Raises US$1.4 Million In Venture Financing 13
Islet Sciences Secures US$0.53 Million In Venture Financing 14
Islet Sciences Secures US$1.1 Million In Venture Financing 15
Partnerships 16
Islet Sciences Enters Into Agreement With Spring Point Project 16
Licensing Agreements 17
Islet Sciences Enters into Licensing Agreement with Brighthaven Ventures for Remogliflozin Etabonate 17
Islet Sciences Enters Into Licensing Agreement With University of California 18
Islet Sciences Enters Into Licensing Agreement With Winthrop-University Hospital For Beta Cell Loss Measurement Technology 19
Acquisition 20
Islet Sciences Completes Acquisition Of DiaKine Therapeutics, Diabetes Drug Maker 20
Islet Sciences Inc - Key Competitors 22
Key Employees 23
Locations And Subsidiaries 24
Head Office 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List Of Tables


Islet Sciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2014 1
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Islet Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Islet Sciences Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Islet Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Islet Sciences Raises USD0.03 Million in Financing Round 11
Islet Sciences Raises US$0.7 Million In Venture Financing 12
Islet Sciences Raises US$1.4 Million In Venture Financing 13
Islet Sciences Secures US$0.53 Million In Venture Financing 14
Islet Sciences Secures US$1.1 Million In Venture Financing 15
Islet Sciences Enters Into Agreement With Spring Point Project 16
Islet Sciences Enters into Licensing Agreement with Brighthaven Ventures for Remogliflozin Etabonate 17
Islet Sciences Enters Into Licensing Agreement With University of California 18
Islet Sciences Enters Into Licensing Agreement With Winthrop-University Hospital For Beta Cell Loss Measurement Technology 19
Islet Sciences Completes Acquisition Of DiaKine Therapeutics, Diabetes Drug Maker 20
Islet Sciences Inc, Key Competitors 22
Islet Sciences Inc, Key Employees 23

List Of Figures


Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Islet Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9

Pancreatic Islet Transplant Rejection (Immunology) - Drugs in Development, 2021

Pancreatic Islet Transplant Rejection (Immunology) - Drugs in Development, 2021Pancreatic Islet Transplant Rejection (Immunology) - Drugs in Development, 2021 provides an overview of the Pancreatic Islet Transplant Rejection pipeline landscape.The

USD 2000 View Report

Islet Amyloid Polypeptide - Pipeline Review, H2 2019

Islet Amyloid Polypeptide - Pipeline Review, H2 2019According to the recently published report Islet Amyloid Polypeptide - Pipeline Review, H2 2019; Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or

USD 3500 View Report

Interpace Biosciences Inc (IDXG) - Product Pipeline Analysis, 2020 Update

Interpace Biosciences Inc (Interpace Biosciences) formerly Interpace Diagnostics Group Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic

USD 750 View Report

Caris Life Sciences Inc - Product Pipeline Analysis, 2020 Update

Caris Life Sciences Inc (Caris Life) is a biotechnology company. The companys molecular scientific offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available